Related by context. All words. (Click for frequent words.) 85 immunotherapies 2A/Furin 70 2A/Furin 68 diagnostic molecular imaging 68 oncolytic virus therapies 68 innovative signaling pathway 68 immunotherapeutic approaches 67 subsidiaries visit http:/www.apricusbio.com 66 molecular therapeutics immunotherapies 66 Crofelemer budesonide foam 66 Personalized Immunotherapy 66 molecular chaperone regulation 66 GVAX ® 66 visit www.genenews.com 66 Chimigen TM 66 therapeutic monoclonal antibodies 66 acne impetigo 66 Exploit collaboration 66 gastro intestinal inflammation 65 technology visit http:/www.genmab.com 65 topical anti infective 65 Protexia ® 65 Nanobody R 65 Evoltra ® 65 investigational hepatitis B 65 candidates Azedra TM 65 MOVIPREP R 65 kidney urologic 65 TRIOLEX HE# APOPTONE HE# 65 immunology oncology 65 HepDirect R 65 commercialize Aganocides 65 treat GI GVHD 65 InterfeRx 65 Immunotherapeutic 65 novel anti infective 65 VISICOL R 64 anti infective treatments 64 developing TB4 64 GVAX Immunotherapies 64 Intermezzo ® zolpidem tartrate 64 topical dermatology 64 Selective Electrochemical Tumor Ablation 64 visit www.genmab.com 64 lead molecular radiotherapeutic 64 Solazed TM 64 Eligard R 64 ALN PCS 64 UltiMAb 64 purinergic receptors P#X# 64 NovaBay Aganocide compounds 64 Vaxfectin 64 using VIAdel TM 64 ALTROPANE R 64 Onalta TM 64 P#X# antagonist 64 MediGene focuses 64 AzaSite Xtra 64 systemic immunosuppressive drugs 64 immuno therapeutic 64 TransVax ™ 64 HuMax TAC 64 Oracea TM 64 DPX Survivac 64 FOLOTYN ® 64 Surfaxin LS 64 therapeutics diagnostics 64 ddRNAi 63 regenerative medicine therapies 63 repopulate CNS 63 molecular imaging radiopharmaceutical 63 Genasense evaluating 63 LNP formulations 63 IMiDs 63 acetonide FA 63 Orphan Drug designation 63 oral transdermal 63 Adnectin 63 investigational therapies 63 PGL# 63 Receives Orphan Drug 63 commercialize becocalcidiol patented 63 SuperAntibody 63 therapeutic peptide 63 FDA Orphan Drug 63 InterfeRx TM 63 personalized dendritic 63 fund BioSante LibiGel 63 faropenem 63 PORxin TM 63 biotherapeutic drugs 63 POTELLIGENT R 63 intranasal delivery 63 Cerashield 63 Combivir Kivexa 63 Aganocide 63 LibiGel ® 63 rxRNA 63 Nanobody ® 63 Initiates Enrollment 63 therapeutic monoclonal antibody 63 Valortim TM 63 plasmid DNA pDNA 63 successfully commercialize Iluvien 63 OLIGON technology 63 targeting Inflammatory Bowel 63 HuCAL R 62 Cx# [002] 62 acyclovir Lauriad R 62 MyVax ® 62 Reports Preclinical Data 62 novel emulsion formulation 62 intravenous formulations 62 fusion enhancers 62 oral taxane 62 VaxImmune 62 SCIB1 62 platinum chemotherapeutic 62 include ClindaReach TM 62 novel oral anticoagulant 62 PER.C6 r 62 candidate deforolimus 62 reformulates existing FDA 62 platforms GVAX 62 please visit www.advaxis.com 62 Dyax phage display 62 vivo fluorescence imaging 62 Veronate R 62 Zemiva TM 62 Micromet BiTE 62 Kosan dependence 62 XL# XL# XL# XL# 62 TRANSDUR ™ 62 Orphan Drug designations 62 XmAb ® 62 commercializing anti infective 62 targeted radiotherapeutic 62 visit www.targanta.com 62 anti emetic therapy 62 novel VDA molecule 62 Viprovex TM 62 Cobalamin TM mediated 62 vaccines oncolytic virus 62 NuMimetic TM 62 Nicotine Conjugate Vaccine 62 molecular imaging radiopharmaceuticals 62 COMPLEGENT TM Technologies 62 MAGE A3 ASCI 62 Completes Patient Enrollment 62 XL# anticancer compounds 62 novel immunotherapies 62 proprietary PEGylation 62 Pruvel TM 62 Zemiva TM Trofex TM 62 sorafenib tablets 62 immunotherapeutics 62 BiovaxID TM 62 TransVax tm 62 MAXY G# 62 recombinant biopharmaceutical 61 include PLX IBD 61 CCR9 antagonist 61 SynCon 61 CYT# potent vascular disrupting 61 Initiates Phase II 61 Nektar proprietary 61 Generx TM 61 proprietary albumin fusion 61 AdVac 61 rhPDGF BB platform 61 Insegia 61 Panzem R NCD 61 PEG SN# 61 OTCBB HXBM developer 61 recombinant subunit vaccine 61 Alnylam RNAi 61 Modrenal R 61 Shigamabs ® 61 regenerative stem cell 61 Civacir 61 Selzentry Celsentri 61 virosome 61 PrevOnco 61 RNA antagonists 61 small molecule thrombopoietin 61 drug ISA# 61 Cellegesic 61 novel RNAi therapeutics 61 TM Aganocide 61 CCR5 mAb 61 immunotherapeutic vaccine 61 PharmFilm ® 61 MyVax R 61 HCD# [002] 61 SinuNase ™ 61 cicletanine 61 HPV cervical dysplasia 61 R MSCRAMM 61 Orphan Drug status 61 MCSP respectively 61 Dual Opioid TM 61 Intravenous CP 61 equine osteoarthritis marketed 61 IMiDs ® compound 61 EP #R 61 Receives Fast Track 61 Maxy G# 61 Alferon LDO 61 avian influenza viral infections 61 anticancer therapeutics 61 ZFP Therapeutics 61 Potelligent Technology 61 palonosetron hydrochloride Injection Dacogen 61 Initiates Clinical Trial 61 Xcytrin R 61 Shigatoxin producing E. coli 61 virology immunology 61 autoimmune indications 61 inflammatory autoimmune diseases 61 Aganocide ® 61 selective androgen receptor modulators 61 NeutroPhase TM 61 POTELLIGENT ® 61 PEGylated interferon 61 diagnostics therapeutics 61 proprietary capillary aerosolization 61 RECOTHROM R 61 Inc Therapeutic Competitors 61 Exelixis compounds 61 MEK inhibitors 61 therapy Atrigel R 61 Fast Track Status 61 tezampanel NGX# 61 cosmetic cosmeceutical products 61 LentiVector technology 61 sapacitabine CYC# 61 DIFICID ™ 61 novel therapeutic antibodies 61 PharmFilm R 61 MassARRAY ® 61 BioVant 61 PORxin TM platforms 61 please visit http:/www.sunesis.com 61 Levulan ® PDT 61 muco adhesive technology 61 ONCASPAR 61 mertansine 61 BCR ABL inhibitors 61 personalized immunotherapy 61 COLAZAL R 61 ophthalmology dermatology 61 Cytolin R 61 LEAPS TM 61 prophylactic vaccines 61 OxBC 61 topically applied SEPA 61 regarding Aethlon Medical 61 Thiovir 61 Captisol enabled 61 Vaxfectin TM 61 Liprotamase 61 candidate CRLX# 61 ClindaReach ® 61 anticoagulant reversing agent 61 please visit www.middlebrookpharma.com 61 Xcellerex FlexFactory 60 visit http:/www.mannkindcorp.com 60 5 lipoxygenase inhibitor 60 NurOwn 60 Vaccine Adjuvant 60 PDE4 inhibitor 60 CD# CEA 60 HuCAL antibodies 60 anti CD# antibodies 60 markets HP Acthar 60 Captisol ® 60 Edurant 60 siRNA therapeutics 60 AdVac ® 60 Bionate ® PCU 60 Aviptadil 60 GeoVax HIV AIDS 60 Panzem R 60 infectious diseases autoimmune diseases 60 CEDAX ® 60 TRANSDUR ® 60 Aloxi ® 60 HepeX B 60 LGLS 60 Novartis NVS Snapshot Report 60 immatics 60 forodesine 60 SYCREST 60 candidate TNFerade biologic 60 Inc. www.micromet inc.com 60 include Altastaph TM 60 StaphVAX R 60 Aeolus Pharmaceuticals Announces 60 Restoraderm 60 Solazed ™ 60 please visit www.metabolon.com 60 SIX RO ROG 60 oral picoplatin 60 LEVADEX ™ 60 Poly ICR 60 therapeutic anticancer 60 Cerashield ™ 60 DNA methylation biomarkers 60 detection reagents 60 prostone 60 Opterone R 60 Multiferon 60 thiazolides 60 HCV protease inhibitors 60 Homspera TM 60 ImmunoGen TAP technology 60 photodisinfection 60 IMPACS R 60 PNP inhibitor 60 Octreolin 60 novel peptides 60 mucosal vaccines 60 RECOTHROM ® 60 BC SeraPro ™ 60 Charlesson 60 IAP inhibitors 60 please visit http:/www.atherogenics.com 60 proprietary intranasal insulin 60 TOCOSOL Camptothecin 60 Iluvien ® 60 OMNARIS HFA 60 subcutaneous formulation 60 Celator 60 DURECT proprietary 60 TKM PLK1 60 Fludara ® 60 Nutra Pharma wholly owned 60 infectious diseases autoimmune 60 Resurgex Plus R 60 Presents Preclinical 60 epigenetic therapies 60 overactive bladder VANTAS R 60 topical anti infectives 60 IMiDs ® 60 GTC recombinant human 60 Submits Response 60 Initiates Phase III 60 Protexia R 60 pDNA vaccine 60 monoclonal antibody therapeutics 60 Receives Orphan Drug Designation 60 Roche SWX ROG 60 YONDELIS 60 novel immunomodulatory 60 Lumacan 60 BHT DNA 60 MSCRAMM ® 60 liposomal delivery 60 delivers fluocinolone acetonide FA 60 Transdel TM platform 60 JAK2 inhibitor 60 opinions visit blog.radvision.com 60 tiapamil 60 Revimmune TM 60 MEK Inhibitor 60 accumulate preferentially 60 Alfacell proprietary ribonuclease 60 Kuvan R 60 hyperimmune products 60 EMCORE Photovoltaic segment 60 Crucell genetically engineered 60 NEUGENE 60 PD2i ® algorithm 60 orally administered inhibitor 60 protein kinase inhibitors 60 SPL# Gel vaginal microbicide 60 MorphoSys proprietary 60 Lovaza TM 60 Virium 60 developing Zerenex ferric 60 Bellicum 60 class mGluR5 inhibitor 60 prescription dermatological 60 Initiate Clinical Trial 60 EGRIFTA TM 60 Locked Nucleic Acid 60 Onalta 60 Synerx 60 investigational monoclonal antibody 60 aerosolized AAT 60 ViroChem 60 M# rationally 60 TKB# 60 RELISTOR ® 60 Alnylam #x# 60 ALN RSV program 59 NanoStat 59 Avian Transgenic Technology 59 Behcet uveitis 59 oral talactoferrin 59 ELADUR ™ 59 Myocet 59 Biochronomer 59 Prednisporin TM 59 Nektar PEGylation technology 59 XmAb 59 Fibrin MB 59 Ibis T# TM 59 atopic dermatitis neonatal 59 Vaccinex 59 Ceragenin ™ 59 developing ACAPODENE 59 lintuzumab SGN 59 CoTherix logo 59 endothelin antagonist 59 Azedra TM Onalta TM 59 EndoTAG TM 59 HIV integrase inhibitors 59 dietary supplement formulated 59 HEPLISAV ™ 59 ChimeriVax JE 59 Luveris R Ovidrel R 59 Sopherion 59 TransVax TM 59 UltiMAb ® 59 HEPLISAV TM hepatitis B 59 migraine headaches neuropathic pain 59 prokinetic agent 59 biochemical profiling 59 Cardium Therapeutics TM 59 humanized monoclonal antibodies 59 Bioral 59 Vitamin D analogue 59 systemic RNAi therapeutic 59 phage display technology 59 blood clot dissolver 59 Submits NDA 59 Submits Biologics License Application 59 Femprox ® 59 TRAIL receptor antibodies 59 Ketotransdel TM 59 Copegus R 59 Temodar ® 59 Taiho Pharmaceutical 59 vapreotide acetate 59 pharmacogenomic translational research 59 Bioral Amphotericin B 59 biosensor functionalization 59 Tibotec Therapeutics division 59 TLR antagonists 59 AFFITOME R 59 recombinant antibodies 59 Launches Generic Version 59 Fibrosis Foundation Therapeutics 59 vitreoretinal disorders 59 low toxicity bioscience 59 selective immunoproteasome inhibitor 59 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 59 selective estrogen receptor modulator 59 patented Bioral 59 Hepatitis C Virus HCV 59 Panzem NCD 59 IL# PE#QQR 59 R sorafenib tablets 59 Shigamabs R 59 Provectus Pharmaceuticals specializes 59 OTCBB PYTO 59 AAG geldanamycin analog 59 Boehringer Ingelheim MedImmune 59 PEGylation technology 59 Inc. NASDAQ IDMI 59 rxRNA compounds 59 tivozanib AV 59 Receives Approvable Letter 59 Initiates Clinical 59 OTCQB ABPI 59 oral prodrug 59 Zavesca r 59 adrenergic regulation 59 Nasdaq ENZN 59 VitiGam 59 products Oncaspar ® 59 Canvaxin TM 59 attach auristatin 59 Oncosphere System 59 Onalta ™ 59 CINTREDEKIN BESUDOTOX 59 please visit www.medicinova.com 59 EpiCept NP 1 59 oral nucleoside analogue 59 humanized therapeutic 59 Wafer polifeprosan 59 HPV cervical cancer 59 CYT# novel 59 eTag assays 59 valent pneumococcal conjugate vaccine 59 Allovectin 7 r 59 synthetic peptide containing 59 leading lipid nanoparticle 59 THALOMID 59 Nivestim 59 Licenses Novel 59 Granted Orphan Drug 59 hypoxia activated prodrug 59 Oncaspar 59 xMAP technology 59 Preclinical studies suggest 59 VersaFilm 59 SMaRT ™ 59 DETERx ™ 59 AVP #D# 59 immuno inflammatory diseases 59 Announce License Agreement 59 PANVAC VF 59 Therapeutic Competitors Companies 59 refractory APL 59 include Alferon N 59 product BioThrax ® 59 novel L DOS# 59 resorbable biomaterials 59 Marqibo TM 59 PRN FDA Approves 59 MKC# MT 59 SansRosa 59 Receive Milestone Payment 59 superior bioprocessing 59 candidate AQ4N 59 oncolytic 59 testosterone buccal system 59 hepatitis B immune globulin 59 AstraZeneca AZN.L 行情 59 Simulect 59 neurology immunology 59 TKM ApoB 59 BC SeraPro proteomic 59 PDE4 modulators 59 vitro diagnostic kits 59 apricitabine ATC 59 herpetic keratitis 59 PolyCides 59 cervical breast 59 VitiGam TM 59 fluoroquinolone class 59 MediVas 59 Archexin 59 Nasdaq RXII 59 punctal plug delivery 59 candidate REP# 59 CMV vaccine 59 Prodarsan R 59 non porcine pancreatic 59 XL# XL# 59 utilizes InSite Vision 59 intranasal insulin product 59 oropharyngeal candidiasis OPC 59 ChronVac C R 59 Inc. AMEX YMI 59 SynCon TM 59 Vaxfectin ® 59 ZADAXIN ® 59 biodefense vaccines 59 HepaGam B 59 JAK inhibitors 59 forodesine hydrochloride 59 TÎ ² 4 59 ABILIFY ® 59 metaglidasen 59 Visit www.BASInc.com 59 Dicer Substrate Technology 59 Inc. NASDAQ BPAX 59 VivaGel TM 59 Gonal f R 59 synthetic retinoid 59 Bioral ® 59 TLR9 agonist 59 Japanese Encephalitis Vaccine 59 CYCLOSET ® 59 miRNA therapeutics 59 Begins Dosing 59 plaque excision systems 59 biodefense pathogens 59 Intravenous Human 58 commercialize conjugates consisting 58 ospemifene 58 candidate epratuzumab 58 Twinject ® 58 Divigel R 58 Firazyr ® 58 ionotropic glutamate receptor antagonists 58 ProEthic Pharmaceuticals 58 severe degenerative ischemic 58 Imvamune 58 oral PTH 58 antiinfective 58 Atripla combines 58 Kristalose R 58 treats acute lymphoblastic 58 investigational pharmacologically unique 58 Receives Milestone Payment 58 AFFITOME 58 proprietary MSCRAMM protein 58 PentaStaph 58 muscarinic receptor agonists 58 Synerx Pharma 58 proprietary BiTE ® 58 Peginterferon alfa 2b 58 Viral Immunotherapy platform 58 ImQuest 58 markets COLAZAL 58 Aerosurf 58 targeted antifolate 58 biologic therapeutics 58 platform HDL Mimetic 58 vaginally administered lidocaine 58 Thrombin topical Recombinant 58 oral salmon calcitonin 58 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 58 cutaneous T 58 Altastaph 58 colorectal bladder 58 Nasulin ™ 58 InterfeRx license 58 cyclophilin inhibitor 58 ADP receptor antagonist 58 Cephalon Oncology 58 hyaluronidase enzyme 58 MDx tests 58 Helinx technology 58 tubulin inhibitor 58 relapsed leukemia 58 XP# XP# 58 Locked Nucleic Acid LNA 58 treat male hypogonadism 58 IoGen 58 PrevOnco ™ 58 equine osteoarthritis 58 Solazed 58 rheumatoid arthritis thrombocytopenia 58 Protexia 58 Fortical R 58 topical NSAID 58 SARMs 58 TetraLogic 58 include Healive 58 INSPIRE Trial Phase III 58 Elotuzumab 58 ZARS Pharma 58 LHRH antagonist 58 Iluvien TM 58 Viread tenofovir disoproxil fumarate 58 DXL TM 58 Ceragenin ™ technology 58 Pyridorin 58 OvaRex R 58 chemical entities NCEs 58 histone deacetylase HDAC inhibitors 58 ® bortezomib 58 DepoVax TM 58 TOCOSOL Paclitaxel 58 CR# vcMMAE 58 Lipocine 58 PER.C6 ® production 58 AN# novel 58 GRNVAC1 58 interferon gamma 1b 58 Maribavir 58 ophthalmic diseases 58 essential thrombocythemia ET 58 Sangamo ZFP technology 58 Martin Nicklasson CEO 58 GED aPC 58 Allovectin 7 R 58 Cancidas 58 LNA TM 58 NTDDS 58 www.soliris.net 58 HepDirect 58 DOS# 58 dirucotide MBP# 58 MAXY VII 58 DCVax R 58 delivers sumatriptan 58 SNALP technology 58 ZK EPO 58 HuMax CD#b 58 commercialize Aganocide compounds 58 THR beta agonist 58 Announces Poster Presentations 58 serious systemic Staphylococcal 58 Inc. NASDAQ ZLCS 58 AVAX AC Vaccine 58 Foradil Aerolizer 58 proprietary MSCRAMM ® 58 Oasmia 58 TESARO 58 BioWa 58 product platforms GVAX 58 anti CD# monoclonal 58 Kiadis 58 Ganite ® 58 Sebivo 58 antigen sparing 58 CoVal TM fusion 58 Pegloticase 58 Awarded Qualifying Therapeutic 58 oral proteasome inhibitor 58 GelSite ® 58 ophthalmology dermatology cardiovascular disease 58 Trofex 58 muscarinic receptor agonist 58 refractory chronic lymphocytic 58 YONDELIS R 58 Ibis T# 58 Septin9 biomarker 58 proprietary transdermal 58 Pictometry customizes 58 Quark Biotech 58 Novantrone R 58 proven DuraSite ® 58 torezolid phosphate 58 Exherin 58 R Saizen R 58 HuCAL PLATINUM R 58 NS5b 58 NEUMUNE 58 Disease IBD 58 neuro inflammatory 58 Inotek Pharmaceuticals Corporation 58 RhuDex ® 58 Zorbtive TM 58 DURIN TM 58 KL4 surfactant 58 please visit http:/www.vandapharma.com 58 Phase 2a clinical trials 58 Aloxi R 58 TP# CETi 1 58 Loramyc TM 58 hoFH 58 Nycomed GmbH 58 HuCAL ® 58 coronary stent merged 58 Announces Tentative Approval 58 Cumulase 58 Loramyc ™ 58 sapropterin dihydrochloride Tablets 58 injectable depot 58 containing LABAs 58 Corixa Corporation 58 fungal infections malaria tuberculosis 58 radionuclide therapy 58 URG# 58 immunoassay kits 58 Litx 58 aldehyde dehydrogenase ALDH2 deficiency 58 Vaxfectin R 58 Rhein Biotech GmbH 58 scalable PLX PLacental 58 pralatrexate injection folate analogue 58 candidates bavituximab 58 NasdaqGM SPPI 58 rolapitant 58 Gord Froehlich President 58 MVA BN R 58 orthobiologic 58 Company patented BEMA 58 Nasdaq HALO biopharmaceutical 58 cleavable linker 58 bioinformatic approaches 58 Profectus BioSciences 58 TELINTRA 58 http:/www.cytrx.com 58 deCODE Genetics Illumina Navigenics 58 Emtriva Viread 58 compound Protectan CBLB# 58 Rexahn licensees 58 Nventa proprietary CoVal 58 Other ImmunoGen collaborative 58 VSEL technology 58 Ltd. Amex SVA 58 LymphoStat B TM 58 TLR agonists 58 Tibotec BVBA 58 VivaGel ™ 58 Rebif ® 58 Angiocept 58 IAP inhibitor 58 Prednisporin 58 commercializes oncology 58 SUMAVEL 58 autoimmune cardiovascular 58 commercialize ZYFLO CR 58 Bioral Amphotericin B. 58 vitamins minerals herbal 58 VeraTag 58 eligen R technology 58 ELADUR TM 58 mitogen activated ERK kinase 58 genetically engineered recombinant protein 58 Files IND 58 Crop BioScience 58 drugs FUSILEV 58 Corp. Nasdaq BSTC 58 romazarit 58 EpiTherapeutics 58 urologic disease 58 rheumatoid arthritis psoriasis 58 Affimed 58 Aganocide TM 58 dermatology therapies 58 GlycoPEGylated hemostasis compounds 58 rheumatoid arthritis inflammatory bowel 58 proprietary electrochemical 58 aptamer therapeutics 58 systemic RNAi 58 predictive toxicology 58 fluorinated carbohydrate mimics 58 commercializing Loramyc ® 58 sublingual tablets 58 topical emulsion 58 patented bacterial oxidation 58 EHT AGN 58 dermatological disorders 58 conventional monoclonal antibodies 58 proprietary intravenous formulation 58 Anidulafungin 58 reslizumab 58 exclusive sublicense 57 IMA# 57 androgen receptor antagonist 57 SynCon ™ DNA 57 intradermal delivery 57 Gamunex C 57 U1 Adaptors 57 RECEPTORS 57 virus HCV protease inhibitor 57 Nasdaq ALNY 57 Nektar pulmonary 57 antisense drugs 57 Mepact 57 nasal calcitonin product 57 clinically validated targets 57 silver dihydrogen citrate 57 VTAs 57 Virulizin ® 57 CDP# 57 GLASSIA ™ 57 Orapred ODT 57 Antibody Drug Conjugate 57 topically delivered 57 NovaDel oral spray 57 Metabasis stockholders 57 pregabalin Lyrica 57 candidate NGX 57 transcatheter valve technologies 57 vinorelbine emulsion 57 Crucell PER.C6 ® 57 HCV polymerase 57 Epothilones 57 FDA APPROVES 57 ESTRASORB 57 VALSTAR TM 57 stable nucleic acid 57 methylnaltrexone bromide 57 gel formulations 57 HydroFix 57 Tezampanel 57 staphylococcal vaccines 57 sumatriptan DosePro 57 L BLP# 57 Altera Nebulizer System 57 molecular imaging pharmaceuticals 57 smallpox SIGA 57 HuMax 57 radezolid 57 TaiGen 57 neuroprotective properties 57 Pruvel 57 Astex Therapeutics Limited 57 DNAwithPap TM Test 57 OTCBB PWRM.OB 57 Therapeutic antibodies 57 HuLuc# 57 IMiDs R 57 Argatroban 57 Aurexis 57 ONCONASE R 57 intranasal vaccines derived 57 APC Targeting Technology 57 polymer conjugate technology 57 Inc. OTCBB MIVT 57 Adagen ® 57 Development OOPD 57 ADVEXIN p# therapy 57 Medarex UltiMAb R 57 please visit www.lexpharma.com 57 Hybridon 57 next generation URAT1 57 Friedreich Ataxia FRDA 57 Prochymal TM 57 injectable antithrombotics 57 Nanomedicine Nanomedicine 57 CysDisplay 57 website www.internationalstemcell.com 57 KL4 Surfactant 57 Zenyaku Kogyo 57 Bacterin develops manufactures 57 PROfusion 57 TOCOSOL 57 ESTRASORB ® 57 Orphan Drug Status 57 QUADRAMET R 57 SynCon ™ 57 Zenvia ™ 57 proprietary biomaterials 57 Resurgex R 57 potent recombinant 57 liposomal formulation 57 technology platforms photodynamic 57 antiviral antibacterial 57 BioMimetic seeks 57 bloodroot shark cartilage 57 ERYtech Pharma 57 ALN TTR 57 HYVISC R 57 taribavirin 57 Ambrx 57 INVANZ 57 AdVac R 57 Alfa Wassermann 57 superparamagnetic iron oxide nanoparticles 57 Lipofen 57 JAK1 57 tests miRview TM 57 neuro inflammatory disorders 57 PDX pralatrexate 57 Shrink OTCBB INKN 57 Accelerating apoptosis may 57 Cancer Vaccines 57 Fleximer R 57 selective kinase inhibitor 57 cancer immunotherapies 57 DELATESTRYL R 57 Triapine 57 metastatic carcinoid 57 Tostrex 57 Galderma SA 57 Nasdaq MNKD focused 57 GERD migraine headaches 57 PHX# 57 COLAZAL ® 57 identify protein biomarkers 57 Nasdaq MITI biopharmaceutical 57 ZFNs clinical trials 57 Nasdaq SPPI 57 proprietary bioresorbable polymer 57 SAR# [002] 57 selectively modulate 57 REGiMMUNE 57 LentiVector 57 TFChem licenses 57 TIMERx 57 ZEFTERA TM Zevtera TM 57 Therapeutic Competitors companiesandmarkets.com adEgemonye 57 small molecule PEGylation 57 Tarmogen 57 Somatuline Depot 57 RNA therapeutics 57 Saizen R 57 DNA RNA Medicines 57 Endotis 57 bendamustine HCl 57 embolotherapy 57 optical biosensors 57 predictive biomarkers 57 novel anticancer 57 patented NanoStat ™ 57 INTELLITAB TM 57 Capsulution 57 Virosome Biologicals 57 Cerashield TM 57 OvaRex ® MAb 57 DNA methyltransferase inhibitors 57 POSIDUR TM ELADUR TM 57 Avro objective 57 TLR8 agonist 57 either acutely decompensated 57 Zanaflex Capsules TM 57 PAION AG ISIN 57 Factor VIIa 57 non nucleoside HCV 57 histone deacetylase inhibitor 57 anthrax botulism typhoid 57 HydroFix ™ 57 itraconazole Sporanox 57 Theratope 57 Staccato nicotine technology 57 CobaCyte 57 coagulation disorders 57 psoriasis rheumatoid arthritis 57 ocular formulation